三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
外显子21(L858R)和外显子19缺失亚组PFS率对比
外显子21(L858R)和外显子19缺失亚组PFS率对比
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:203KB
图片尺寸:1078*707
同报告图片
/
4
fCBUaW1lIHNpbmNlIFRyZWF0bWVudCBJbml0aWF0aW9uKG1vbnRocykgfCBFeDE5ZGVsIE5vLmF0IFJpc2soY2Vuc29yZWQpIHwgTDg1OFIgTm8uYXQgUmlzayhjZW5zb3JlZCkgfAp8LS0tfC0tLXwtLS18CnwgMCAgfCAxMDAgfCAxMDAgfAp8IDIgIHwgMzMoMCkgfCAzMCgwKSB8CnwgNCAgfCAzMCgwKSB8IDI5KDApIHwKfCA2ICB8IDI5KDApIHwgMjYoMSkgfAp8IDggIHwgMjkoMCkgfCAyNCgyKSB8CnwgMTAgfCAyNigwKSB8IDIyKDMpIHwKfCAxMiB8IDI1KDApIHwgMjAoMykgfAp8IDE0IHwgMjIoMSkgfCAxNCgzKSB8CnwgMTYgfCAyMCgyKSB8IDEzKDMpIHwKfCAxOCB8IDE4KDQpIHwgMTEoMykgfAp8IDIwIHwgMTQoOCkgfCA2KDYpIHwKfCAyMiB8IDkoMTMpIHwgMyg5KSB8CnwgMjQgfCA4KDE0KSB8IDEoMTApIHwKfCAyNiB8IDcoMTUpIHwgMCgxMSkgfAp8IDI4IHwgNygxNSkgfCAwKDExKSB8CnwgMzAgfCAxKDIwKSB8IDAoMjEpIHwKCui1hOaWmeadpea6kO+8mkFTQzDvvIzlpKnpo47or4HliLjnoJTnqbbmiYA=
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
所属报告:
翰森制药-港股公司研究报告-创新能力持续兑现的制药企业兼具业绩稳健与创新弹性-250606(69页).pdf
打包全文图表
相关数据
依沃西为全球首个在三期临床中头对头击败K药的新药,PFS强阳性(HR=0.51)
收藏
行业数据
2026-03-31
原图定位
查看详情
HARMONi-6试验主要终点:依沃西+化疗较对照臂PFS提升4.2个月(HR=0.60)
收藏
行业数据
2026-03-31
原图定位
查看详情
CARTITUDE-4 TME: Patients With Shorter PFS (≤18M) and Patients With More pLOT had a More Suppressive TME
IyMjIOaVsOaNruihqOagvAoKIyMjIyDkuIDjgIHmjIlQRlPliIbnu4TvvIhQRlMgPjE4TSB2cyBQRlMg4omkMThN77yJ55qE57q15ZCR5Yqo5oCBCgp8IOaMh+aghyAgICAgICAgICAgICAgICB8IOaXtumXtOeCuSAgIHwgUEZTID4xOE0gKG4pIHwgUEZTIOKJpDE4TSAobikgfCDnu5/orqHmmL7okZfmgKfvvIhQ5YC877yJIHwKfC0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS18CnwgVHJlZyAgICAgICAgICAgICAgICB8IEJhc2VsaW5lIHwgMTE1ICAgICAgICAgIHwgMjYgICAgICAgICAgIHwgbnMgICAgICAgICAgICAgICAgfAp8ICAgICAgICAgICAgICAgICAgICAgfCBEMjggICAgICB8IDExNSAgICAgICAgICB8IDE4ICAgICAgICAgICB8IG5zICAgICAgICAgICAgICAgIHwKfCAgICAgICAgICAgICAgICAgICAgIHwgNk0gICAgICAgfCAxMTQgICAgICAgICAgfCAxOCAgICAgICAgICAgfCBQIDwgMC4wNSAgICAgICAgICB8CnwgRU1UIHNpZ25hdHVyZSAgICAgICB8IEJhc2VsaW5lIHwgMTE1ICAgICAgICAgIHwgMjYgICAgICAgICAgIHwgbnMgICAgICAgICAgICAgICAgfAp8ICAgICAgICAgICAgICAgICAgICAgfCBEMjggICAgICB8IDExNSAgICAgICAgICB8IDE4ICAgICAgICAgICB8IG5zICAgICAgICAgICAgICAgIHwKfCAgICAgICAgICAgICAgICAgICAgIHwgNk0gICAgICAgfCAxMTQgICAgICAgICAgfCAxOCAgICAgICAgICAgfCBQIDwgMC4wNSAgICAgICAgICB8CnwgUEkzSy9BS1QgcGF0aHdheSAgICB8IEJhc2VsaW5lIHwgMTE1ICAgICAgICAgIHwgMjYgICAgICAgICAgIHwgbnMgICAgICAgICAgICAgICAgfAp8ICAgICAgICAgICAgICAgICAgICAgfCBEMjggICAgICB8IDExNSAgICAgICAgICB8IDE4ICAgICAgICAgICB8IG5zICAgICAgICAgICAgICAgIHwKfCAgICAgICAgICAgICAgICAgICAgIHwgNk0gICAgICAgfCAxMTQgICAgICAgICAgfCAxOCAgICAgICAgICAgfCBQIGFkaiA8IDAuMDUgICAgICB8CgojIyMjIOS6jOOAgeaMiXBMT1TliIbnu4TvvIgxIHBMT1QgdnMgMyBwTE9U77yJ55qE57q15ZCR5Yqo5oCBCgp8IOaMh+aghyAgICAgICAgICAgICAgICB8IOaXtumXtOeCuSAgIHwgMSBwTE9UIChuKSB8IDMgcExPVCAobikgfCDnu5/orqHmmL7okZfmgKfvvIhQ5YC877yJIHwKfC0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tfC0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLXwKfCBUcmVnICAgICAgICAgICAgICAgIHwgQmFzZWxpbmUgfCA0OSAgICAgICAgIHwgMzYgICAgICAgICB8IFAgYWRqIDwgMC4wNSAgICAgIHwKfCAgICAgICAgICAgICAgICAgICAgIHwgRDI4ICAgICAgfCA0MyAgICAgICAgIHwgMzIgICAgICAgICB8IG5zICAgICAgICAgICAgICAgIHwKfCAgICAgICAgICAgICAgICAgICAgIHwgNk0gICAgICAgfCA0NyAgICAgICAgIHwgMzMgICAgICAgICB8IG5zICAgICAgICAgICAgICAgIHwKfCBFTVQgc2lnbmF0dXJlICAgICAgIHwgQmFzZWxpbmUgfCA0OSAgICAgICAgIHwgMzYgICAgICAgICB8IFAgYWRqIDwgMC4wNSAgICAgIHwKfCAgICAgICAgICAgICAgICAgICAgIHwgRDI4ICAgICAgfCA0MyAgICAgICAgIHwgMzIgICAgICAgICB8IG5zICAgICAgICAgICAgICAgIHwKfCAgICAgICAgICAgICAgICAgICAgIHwgNk0gICAgICAgfCA0NyAgICAgICAgIHwgMzMgICAgICAgICB8IG5zICAgICAgICAgICAgICAgIHwKfCBQSTNLL0FLVCBwYXRod2F5ICAgIHwgQmFzZWxpbmUgfCA0OSAgICAgICAgIHwgMzYgICAgICAgICB8IG5zICAgICAgICAgICAgICAgIHwKfCAgICAgICAgICAgICAgICAgICAgIHwgRDI4ICAgICAgfCA0MyAgICAgICAgIHwgMzIgICAgICAgICB8IG5zICAgICAgICAgICAgICAgIHwKfCAgICAgICAgICAgICAgICAgICAgIHwgNk0gICAgICAgfCA0NyAgICAgICAgIHwgMzMgICAgICAgICB8IFAgYWRqIDwgMC4wNSAgICAgIHwKCgojIyMg6LWE5paZ5p2l5rqQCgoqIFByZXNlbnRlZCBieSBTIFBhcmVraCBhdCB0aGUgNjd0aCBBbWVyaWNhbiBTb2NpZXR5IG9mIEhlbWF0b2xvZ3kgKEFTSCkgQW5udWFsIE1lZXRpbmc7IERlY2VtYmVyIDYg4oCTIDksIDIwMjU7IE9ybGFuZG8sIEZMLCBVU0EgIAoqIEZvb3Rub3RlIHJlZmVyZW5jZXM6ICAKICAxLiBBbGFlaWQgRCwgZXQgYWwuIEhhZW1hdG9sb2dpY2EgMjAyMDsxMDUoOSk6ZTQ3MC1lNDczLiAgCiAgMi4gSGVpbmVtYW5uIEwsIGV0IGFsLiBGcm9udGllcnMgaW4gT25jb2xvZ3kgMjAyMjsxMjo4NzQyNTIu
收藏
行业数据
2026-03-11
原图定位
查看详情
CARTITUDE-4: PFS and OS in Patients With Standard-Risk Cytogenetics (As-Treated)
fCDnu4TliKsgfCAzMOS4quaciOaXoOi/m+WxleeUn+WtmOeOh++8iFBGUywgJe+8iSB8IDMw5Liq5pyI5oC755Sf5a2Y546H77yIT1MsICXvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCBDQVJUSVRVREUgLSA0IOagh+WHhumjjumZqSB8IDgwLjUgfCA4Ny4zIHwKfCBDQVJUSVRVREUgLSA0IOagh+WHhumjjumZqSArIGdhaW4vYW1wKDFxKSB8IDcxLjcgfCA4Ni4xIHwKCui1hOaWmeadpea6kO+8mlBBUlRJVFVERSAtIDQg56CU56m277yI5qCH5YeG6aOO6Zmp57uG6IOe6YGX5Lyg5a2m5oKj6ICFIEFzIC0gVHJlYXRlZCDliIbmnpDvvInmlbDmja4=
收藏
行业数据
2026-03-11
原图定位
查看详情
Figure 3: PFS (A) and OS (B)
fCDmjIfmoIcgICAgICAgfCAzNuS4quaciOeOhyB8IDk1JSDnva7kv6HljLrpl7QgfAp8LS0tLS0tLS0tLS0tfC0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS18CnwgUEZTICAgICAgICB8IDkzLjglICAgIHwgNjMuMuKAkzk5LjEgICAgfAp8IE9TICAgICAgICAgfCA5My44JSAgICB8IDYzLjLigJM5OS4xICAgIHwKCui1hOaWmeadpea6kO+8muWbvueJh+S4reKAnFJlc3VsdHPigJ3mnb/lnZflj4pGaWd1cmUgM++8iFBGUyAoQSkg5ZKMIE9TIChCKe+8ieWGheWuueOAgg==
收藏
行业数据
2026-03-11
原图定位
查看详情
T-DXd对HER2-lowBC的全人群PFS
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
收藏
行业数据
2025-11-24
原图定位
查看详情
Ivonescimab国内临床,PFS显著优于K药
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
收藏
行业数据
2025-10-24
原图定位
查看详情
izabren展现EGFRmNSCLC二线治疗历史最长PFS(单位:月)
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
收藏
行业数据
2025-09-16
原图定位
查看详情
Vepdegestrantvs氟维司群在HR+/HER2-BC(全人群)的PFS数据
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
收藏
行业数据
2025-08-08
原图定位
查看详情
R/RCLL最新PFS数据支持BGB-16673开展与匹妥布替尼的头对头试验
fCDpobnnm64gfCBCR0ItMTY2NzMgfCDljLnlronluIPmm7/lsLwgfAp8LS0tLS0tfC0tLS0tLS0tLS18LS0tLS0tLS0tLXwKfCBuICAgIHwgNjYgICAgICAgfCAxMTkgICAgICB8Cnwg5Lit5L2NUEZTLCDmnIggKDk1JSBDSSkgfCAyMi44ICgxNS42KSB8IDE0LjAgKDExLjItMTYuNikgfAp8IOS4reS9jemaj+iuv+aXtumXtCwg5pyIIHwgMTUuNiAgICAgIHwgMTkuNCAgICAgIHw=
收藏
行业数据
2025-08-07
原图定位
查看详情
CELESTIAL-301临床:全球唯一旨在证明相比目前固定疗程标准疗法具有PFS
fCDliIblsYLlm6DntKAgfCBB57uEIHwgQue7hCB8CnwtLS0tLS0tLS0tLXwtLS0tLXwtLS0tLXwKfCDlubTpvoQoPDY15bKB5a+55q+U4omlNjXlsoEpIHwgICAgIHwgICAgIHwKfCBJR0hWKOeqgeWPmOWvueavlOacqueqgeWPmCkgfCAgICAgfCAgICAgfAp8IOaYr+WQpuS8tOaciTE3cOe8uuWksS9UUDUz56qB5Y+YIHwgICAgIHwgICAgIHwKCui1hOaWmeadpea6kO+8muWFrOWPuOa8lOekuuadkOaWme+8jOWbvemHkeivgeWIuOeglOeptuaJgA==
收藏
行业数据
2025-08-07
原图定位
查看详情
无明确驱动基因NSCLC(无论PD-L1表达状态),依沃西PFS数据佳,SSGJ-707的ORR及安全性佳
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
收藏
行业数据
2025-07-17
原图定位
查看详情
Tarlatamab在PFS及癌症相关呼吸/咳嗽获益
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
收藏
行业数据
2025-07-15
原图定位
查看详情
戈利昔替尼与西达本胺的PFS曲线对比
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
收藏
行业数据
2025-06-23
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
此外 ACHIEVE 试验还发现,相比较于外显子 21(L858R)突变的患者,阿美替尼在外显子19 缺失的患者身上展现出更佳的疗效。存在外显子 21(L855R)突变患者亚组的中位 PFS为 12.5 个月,外显子 19 缺失患者中位 PFS 为 26.9 个月,两者的风险比(HR)是 2.34。外显子 21(L858R)组患者的中位 PFS 为 20.5 个月,虽然外显子 19 缺失亚组患者的颅内 PFS 尚未达到,但是两组对比的颅内 PFS 率的 HR 值为 4.23,外显子 19 缺失亚组颅内 PFS 率表现更优。
行业数据
原图定位
当前图表所属:
翰森制药-港股公司研究报告-创新能力持续兑现的制药企业兼具业绩稳健与创新弹性-250606(69页).pdf
三代EGFRTKI联用EGFR/C-MET双特异性抗体关于EGFR敏感突变1L治疗适应症的试验进展
三代EGFRTKI药物获批和医保目录纳入情况
HS-20117相关临床试验进度
TYK2药物竞争格局
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》